5/1
06:01 am
iova
Iovance Biotherapeutics to Host First Quarter 2024 Financial Results Conference Call and Webcast on Thursday, May 9, 2024
Medium
Report
Iovance Biotherapeutics to Host First Quarter 2024 Financial Results Conference Call and Webcast on Thursday, May 9, 2024
4/30
06:03 am
iova
Iovance Biotherapeutics to Present at Upcoming Conferences [Yahoo! Finance]
Low
Report
Iovance Biotherapeutics to Present at Upcoming Conferences [Yahoo! Finance]
4/30
06:01 am
iova
Iovance Biotherapeutics to Present at Upcoming Conferences
Low
Report
Iovance Biotherapeutics to Present at Upcoming Conferences
4/29
02:41 pm
iova
With 63% ownership of the shares, Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) is heavily dominated by institutional owners [Yahoo! Finance]
Low
Report
With 63% ownership of the shares, Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) is heavily dominated by institutional owners [Yahoo! Finance]
4/28
02:47 pm
iova
Where Will Iovance Biotherapeutics Stock Be in 5 Years? [Yahoo! Finance]
Medium
Report
Where Will Iovance Biotherapeutics Stock Be in 5 Years? [Yahoo! Finance]
4/25
10:35 am
iova
3 Millionaire-Maker Biotech Stocks [Yahoo! Finance]
Low
Report
3 Millionaire-Maker Biotech Stocks [Yahoo! Finance]
4/24
04:01 pm
iova
Iovance Biotherapeutics to Present Clinical and Translational Data at 2024 ASCO Annual Meeting
Low
Report
Iovance Biotherapeutics to Present Clinical and Translational Data at 2024 ASCO Annual Meeting
4/21
05:13 am
iova
These Biotech Stocks Could Soar 120% and 295%, According to Wall Street [Yahoo! Finance]
Low
Report
These Biotech Stocks Could Soar 120% and 295%, According to Wall Street [Yahoo! Finance]
4/19
05:15 pm
iova
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Low
Report
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
4/17
09:52 am
iova
Is Iovance Biotherapeutics Stock a Buy Now? [Yahoo! Finance]
Low
Report
Is Iovance Biotherapeutics Stock a Buy Now? [Yahoo! Finance]
4/9
08:25 am
iova
Market Sentiment Around Loss-Making Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) [Yahoo! Finance]
Low
Report
Market Sentiment Around Loss-Making Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) [Yahoo! Finance]
4/9
06:14 am
iova
Iovance Biotherapeutics: Riding The Favorable Moment Could Bring Excellent Results [Seeking Alpha]
Low
Report
Iovance Biotherapeutics: Riding The Favorable Moment Could Bring Excellent Results [Seeking Alpha]
4/8
03:40 pm
iova
Iovance (IOVA) Stock Surges More Than 60% YTD: Here's Why [Yahoo! Finance]
Low
Report
Iovance (IOVA) Stock Surges More Than 60% YTD: Here's Why [Yahoo! Finance]
4/5
05:18 am
iova
Better Growth Biotech Buy: Iovance Biotherapeutics vs CRISPR Therapeutics [Yahoo! Finance]
Low
Report
Better Growth Biotech Buy: Iovance Biotherapeutics vs CRISPR Therapeutics [Yahoo! Finance]
3/29
12:57 pm
iova
Iovance Biotherapeutics (IOVA) Down 6.9% Since Last Earnings Report: Can It Rebound? [Yahoo! Finance]
Medium
Report
Iovance Biotherapeutics (IOVA) Down 6.9% Since Last Earnings Report: Can It Rebound? [Yahoo! Finance]
3/25
02:37 pm
iova
Iovance Biotherapeutics: Initial Amtagvi Launch In Focus [Seeking Alpha]
Low
Report
Iovance Biotherapeutics: Initial Amtagvi Launch In Focus [Seeking Alpha]
3/22
05:30 pm
iova
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Medium
Report
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
3/19
04:19 pm
iova
Iovance Biotherapeutics (NASDAQ:IOVA) shareholders are still up 122% over 1 year despite pulling back 7.1% in the past week [Yahoo! Finance]
Medium
Report
Iovance Biotherapeutics (NASDAQ:IOVA) shareholders are still up 122% over 1 year despite pulling back 7.1% in the past week [Yahoo! Finance]
3/19
07:17 am
iova
ISPE Announces a Regulatory Focus at the 2024 ISPE Europe Annual Conference with Health Authority Representatives from the US, United Kingdom, and Europe [Yahoo! Finance]
Low
Report
ISPE Announces a Regulatory Focus at the 2024 ISPE Europe Annual Conference with Health Authority Representatives from the US, United Kingdom, and Europe [Yahoo! Finance]
3/18
03:06 pm
iova
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) had its price target raised by analysts at Piper Sandler from $18.00 to $19.00. They now have an "overweight" rating on the stock.
Low
Report
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) had its price target raised by analysts at Piper Sandler from $18.00 to $19.00. They now have an "overweight" rating on the stock.
3/18
02:07 am
iova
Forget Eli Lilly. Buy This Magnificent Biotech Stock Instead [Yahoo! Finance]
Low
Report
Forget Eli Lilly. Buy This Magnificent Biotech Stock Instead [Yahoo! Finance]
3/7
06:10 am
iova
1 Wall Street Analyst Thinks Iovance Biotherapeutics Stock Is Going to $32. Is It a Buy Around $17? [Yahoo! Finance]
Low
Report
1 Wall Street Analyst Thinks Iovance Biotherapeutics Stock Is Going to $32. Is It a Buy Around $17? [Yahoo! Finance]
3/6
04:48 am
iova
Iovance Biotherapeutics Stock Has 22% Upside, According to 1 Wall Street Analyst [Yahoo! Finance]
Low
Report
Iovance Biotherapeutics Stock Has 22% Upside, According to 1 Wall Street Analyst [Yahoo! Finance]
3/5
02:18 pm
iova
FDA Lifts Clinical Hold on Iovance's (IOVA) Lung Cancer Study [Yahoo! Finance]
Low
Report
FDA Lifts Clinical Hold on Iovance's (IOVA) Lung Cancer Study [Yahoo! Finance]
3/4
06:30 am
iova
Iovance Biotherapeutics Announces FDA has Lifted Clinical Hold on the IOV-LUN-202 Registrational Trial in Non-Small Cell Lung Cancer
Low
Report
Iovance Biotherapeutics Announces FDA has Lifted Clinical Hold on the IOV-LUN-202 Registrational Trial in Non-Small Cell Lung Cancer